BriaCell Therapeutics Corp. Share Price
BCTXBriaCell Therapeutics Corp. Stock Performance
Open $3.19 | Prev. Close $3.08 | Circuit Range N/A |
Day Range $3.10 - $3.20 | Year Range $0.61 - $13.78 | Volume 4,342 |
Average Traded $3.15 |
BriaCell Therapeutics Corp. Share Price Chart
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
BriaCell Therapeutics Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
29-Jun-26 | $3.19 | $3.11 | +0.00% |
29-Jun-26 | $3.19 | $3.11 | +0.97% |
26-Jun-26 | $2.94 | $3.08 | +3.01% |
25-Jun-26 | $3.07 | $2.99 | -2.29% |
24-Jun-26 | $3.06 | $3.06 | +0.66% |
23-Jun-26 | $3.05 | $3.04 | +0.00% |
22-Jun-26 | $3.02 | $3.04 | +4.65% |
FAQs on BriaCell Therapeutics Corp. Share Price
Can I buy BriaCell Therapeutics Corp. shares in India?
What is the share price of BriaCell Therapeutics Corp.?
What is the 5 year returns of BriaCell Therapeutics Corp.?
What are the high & low stock price of BriaCell Therapeutics Corp. today?
What is the 52-week high and low of BriaCell Therapeutics Corp. stock?